Bristol Myers Squibb tops quarterly estimates, hikes outlook as drugmaker braces for tariffs
The guidance revisions include the estimated impact of current tariffs on U.S. products shipped to China, but not Trump's planned pharmaceutical tariffs.
Myers Squibb
since
auto-detected in 61 stories
15 days ago
Bristol Myers Squibb tops quarterly estimates, hikes outlook as drugmaker braces for tariffs
The guidance revisions include the estimated impact of current tariffs on U.S. products shipped to China, but not Trump's planned pharmaceutical tariffs.
3 months ago
Bristol Myers Squibb plans $2 billion in cost cuts by 2027, issues weak guidance
The company also issued a 2025 guidance that fell short of expectations, as some of the company's older drugs face competition from cheaper generics.
Bristol Myers Squibb plans $2 billion in cost cuts by 2027, issues weak guidance
The company also issued a 2025 guidance that fell short of expectations, as some of the company's older drugs face competition from cheaper generics.
page 1 of 1